Latest Breaking News On - Thai pan - Page 4 : comparemela.com

Share this article Share this article HANGZHOU, China and SAN FRANCISCO, July 11, 2021 /PRNewswire/ Hangzhou Sciwind Biosciences Co., Ltd., a clinical-stage, fast-growing biopharmaceutical company focusing on discovering and developing innovative therapies to treat chronic, metabolic and immunological diseases, announced today the appointment of Dr. Weidong Zhong, former co-founder and executive of Terns Pharmaceuticals, as Chief Strategy Officer and President of its US subsidiary, Sciwind Biosciences USA. Dr. Zhong is a highly accomplished industry leader with an extensive track record in discovering and developing innovative therapies to treat infectious and metabolic diseases, said Hai Pan, Ph.D., founder and CEO of Sciwind. His knowledge and expertise will be very valuable to Sciwind as we advance our differentiated product pipeline through development in China as well as in other global markets. We are thrilled to have Dr. Zhong join us at this critical time in our comp

Smithkline beechamWeidong zhongThai panPrnewswire hangzhou sciwind biosciences co ltdAntiviral research at novartisValeant pharmaceuticalsPlough research instituteTerns pharmaceuticalsBiology at gilead sciencesChief strategy officerSciwind biosciences unitedChief scientific officerAntiviral researchSenior directorGilead sciencesSchering plough research institute